CONTACT US | Phone: 1-800-537-2790
  • COMPANY
    • OVERVIEW
    • QUALITY
    • CAREERS
  • PRODUCTS
    • RENUVION®
    • J-PLASMA®
    • PATENTS
    • SYMBOL GLOSSARY
    • Electronic IFU Portal
    • Electronic IFU Portal
  • INVESTOR RELATIONS
  • BLOG
  • COMPANY
    • OVERVIEW
    • QUALITY
    • CAREERS
  • PRODUCTS
    • RENUVION®
    • J-PLASMA®
    • PATENTS
    • SYMBOL GLOSSARY
    • Electronic IFU Portal
    • Electronic IFU Portal
  • INVESTOR RELATIONS
  • BLOG

2023 Shareholder News

Home » 2023 Shareholder News
By Nick Johnson (Apyx)
In 2023 Shareholder News, Renuvion
Posted February 1, 2023

APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) SUBMISSION FOR THE USE OF THE RENUVION APR HANDPIECE FOR THE COAGULATION OF SUBCUTANEOUS SOFT TISSUES WHERE NEEDED, FOLLOWING LIPOSUCTION

READ MORE
By apyxmedical
In 2023 Shareholder News, Renuvion
Posted January 25, 2023

APYX MEDICAL CORPORATION LAUNCHES NEW ‘APYX ONE CONSOLE’ FOR COSMETIC SURGICAL PROCEDURES IN THE UNITED STATES

READ MORE
By apyxmedical
In 2022 Shareholder News, 2023 Shareholder News, J-Plasma, Renuvion
Posted January 10, 2023

APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2022 REVENUE RESULTS

READ MORE
By apyxmedical
In 2023 Shareholder News, J-Plasma, Renuvion
Posted January 3, 2023

APYX MEDICAL CORPORATION EMBARKS ON INAUGURAL BRAND CAMPAIGN FOR RENUVION

READ MORE

© Copyright 2022 Apyx Medical. All rights reserved. Renuvion®, J-Plasma® and Reshaping What's Possible® are registered trademarks of Apyx Medical Corporation. Bovie® is a registered trademark of Symmetry Surgical. Energy Elevating Lives℠ is a service mark of Apyx Medical Corporation. Apyx™ is a trademark of Apyx Medical Corporation.

Contact Us | Privacy Policy | Terms of Use | Disclaimer

Top